Rock Creek Pharmaceuticals, Inc.
(Other OTC/NBB : STSI)

( )
STSI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.81%175.590.7%$1405.98m
PFEPfizer Inc. -1.83%50.400.9%$1327.23m
ABBVAbbVie, Inc. -1.44%152.551.9%$1169.95m
BMYBristol-Myers Squibb Co. -1.52%77.031.0%$1169.89m
MRKMerck & Co., Inc. -1.02%92.050.7%$1097.17m
LLYEli Lilly & Co. -1.98%295.431.1%$859.74m
AZNAstraZeneca Plc -3.53%63.321.0%$489.96m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.09%141.900.0%$438.60m
VERUVeru, Inc. -3.78%15.010.0%$363.86m
NVSNovartis AG -0.27%87.680.2%$229.58m
GSKGlaxoSmithKline Plc -2.42%43.630.2%$222.90m
HZNPHorizon Therapeutics Plc -4.82%88.425.4%$193.67m
SGENSeagen Inc. -2.42%143.005.7%$174.55m
NVONovo Nordisk A/S -2.61%103.560.1%$171.61m
VTRSViatris, Inc. -1.74%11.270.0%$153.78m

Company Profile

Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.